The reduction of DCLK1 has been shown to inhibit cancer stemness and reduce the regenerative capacity of pancreatic cells (Kim et al. 2022; Westphalen et al. 2016; Weygant et al. 2014). The gene discussed is DCLK1; the disease is cancer.